Citation Information :
Kaura V, Kaura NV, Kaura BN, Kaura CS. Angiotensin-converting Enzyme Inhibitors in the Treatment of Sarcoidosis and Association with ACE Gene Polymorphism: Case Series. Indian J Chest Dis Allied Sci 2013; 55 (2):105-107.
Angiotensin-converting enzyme (ACE) is used as a marker for sarcoid disease activity.1 We present an observational study of four African-American patients all of whom demonstrated improvement in their sarcoidosis after treatment with ACE inhibitors for hypertension.
Leiberman J. Elevation of serum angiotensin-convertingenzyme (ACE) level in sarcoidosis. Am J Med 1975;59:365-72.
Kaura V, Kaura S, Kaura C. Ace inhibitors in the treatment of cutaneous and lymphatic sarcoidosis. Am J Clin Dermatol 2007;8:183-6.
Maliarik MJ, Rybicki BA, Malvitz E, Sheffer RG, Major M, Popovich J Jr, et al. Angiotensin converting enzyme (ACE) gene polymorphism and risk of sarcoidosis. Am J Respir Crit Care Med 1998;158:1566-70.
Silverstein E, Friedland J, Pertschuk LP. Sarcoidosis pathogenesis. Mechanisms of angiotensin converting enzyme elevation: epitheliod cell localization and induction in macrophages and monocytes in culture. In: Jones-Williams W, Davies BH, editors, Proceedings of the 8th International Conference on Sarcoidosis and Other Granulomatous Diseases. Cardiff: Alpha and Omega Press; 1980: p. 246.
Scadding JG, Mitchell DN. Sarcoidosis. London: Chapman and Hall Medical; 1985: pp 181-206.
Suzuki Y, Ortega MR, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II (Review). Int J Biochem Cell Biol 2003;35:881-900.
Mizuno K, Okamoto H, Horio T. Inhibitory influences of xanthine oxidase inhibitor and angiotensin I-converting enzyme inhibitor on multinucleated giant cell formation from monocytes by downregulation of adhesion molecules and purinergic receptors. Br J Dermatol 2004;150:205-10.
Anthony F, Layton AMA. Case of cutanerous acral sarcoidosis with response to allopurinol. Br J Dermatol 2000;142:1052-3.
Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long term therapy with Captopril. Circulation 1985;72:406-12.
Claridge MW, Hobbs SD, Quick C, Day N, Bradbury A, Wilmink A. ACE inhibitors increase type III collagen synthesis a potential explanation for reduction in acute vascular events by ACE inhibitor. Eur J Vasc Endovasc Surg 2004;28:67-70.
Furuya K, Yamaguchi E, Itoh A, Hizawa N, Ohnuma N, Kojima J, et al. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a risk factor for sarcoidosis. Thorax 1996;51:777-80.
Rosenbloom J, Castro SV, Jimenez S. Fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann Intern Med 2010;152:159-66.
